Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Anastrozole/Levonorgestrel IVR with Vaginal Co-medications
NCT02545452Phase 1Completed
- Sponsor
- Bayer
- Start
- Sep 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of anastrozole + levonorgestrel in endometriosis (4 arms), sponsored by Bayer. Primary endpoints: Average concentration (Cav) anastrozole after insertion of the intra-vaginal ring and Average concentration (Cav) levonorgestrel after insertion of the intra-vaginal ring. Started Sep 2015; status: completed.
02
Drugs
anastrozole + levonorgestrel
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02545452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02545452.